← back to search

Martin Eduardo Richardet

Aconcagua University · AR
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Lung Cancer Treatments and Mutations, and Inflammatory Biomarkers in Disease Prognosis.
h-index
15
citations
3,022
works
61
NIH funding
primary concept
Medicine
email

Recent publications

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden
Journal for ImmunoTherapy of Cancer 2024cited by 37position: middledoi
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
New England Journal of Medicine 2021cited by 1,715position: middledoi
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
Cancer 2020cited by 334position: middledoi
Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025
European Urology 2017cited by 240position: middledoi
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
Annals of Oncology 2015cited by 131position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huanyu Zhao · Shenyang Aerospace University1 papers (2017–2017)Hans J. Hammers · Southwestern University1 papers (2017–2017)Ulrika Harmenberg · Karolinska University Hospital1 papers (2017–2017)Hélène Hardy · Janssen (United States)1 papers (2017–2017) · 1 papers (2017–2017)David F. McDermott · Dana-Farber/Harvard Cancer Center1 papers (2017–2017)Yoshihiko Tomita · Niigata University Medical and Dental Hospital1 papers (2017–2017)John Wagstaff · UC Davis Health1 papers (2017–2017)Elizabeth R. Plimack · The University of Texas Southwestern Medical Center1 papers (2017–2017)Alain Ravaud · Hôpital Saint-André1 papers (2017–2017)Howard Gurney · Macquarie University1 papers (2017–2017)Bernard Escudier · Institut Gustave Roussy1 papers (2017–2017)Toni K. Choueiri · Harvard University1 papers (2017–2017)Robert J. Motzer · Texas Oncology1 papers (2017–2017)Frede Donskov · Aarhus University Hospital1 papers (2017–2017)Paweł Zalewski · Medical University of Warsaw1 papers (2017–2017)Padmanee Sharma · The University of Texas MD Anderson Cancer Center1 papers (2017–2017)Jeffrey A. Sosman · Northwestern University1 papers (2017–2017)Saby George · Roswell Park Comprehensive Cancer Center1 papers (2017–2017)